5 Comments
Jan 7, 2023Liked by Health by James

My good friend has autoimmune hepatitis that began after her second Pfizer jab. It has substantially changed her life at 74. The medication she is on makes her diabetic and requires insulin shots daily. She has no clue.

Expand full comment
author

I’m so sorry

Expand full comment

Wow, that is so tough.

Do you think she is zombie-fied enough to go back for more? It's so difficult when they can't connect the dots themselves. Some haven't even a hint of curiosity!

I'm constantly debating if I should say something, or if it would only cause more hurt/pain by bringing it up. I know damn well that the damage is done, not a whole lot they can do to reverse it, and I dont want to send them into a panic.

But it pains me to see them going back for more of these pointless shots.

That's the main reason why I feel obligated to speak up-- trying to convince them to walk away now, while they still can.

Expand full comment

What about those babies who while invetro, their mothers were jabbed????

Will we lose them also?

Expand full comment

James, good morning from Australia

the FDA document above is quite damning

here in Australia Moderna submitted a different series of figures (from the same Study P204) when seeking an extension of 'provisional approval' to babies 6 months to toddlers under 6 years

.. provisional approval here operates like an EUA in the US

equivalent to the FDA, our TGA (Therapeutics Goods Administration) publishes an AusPAR (Australian Public Assessment Report) in respect of any new drug they approve

in respect of babies 6 months through toddlers under 6, that report can be found here:

https://www.tga.gov.au/resources/auspar/auspar-spikevax

.. look at 'AusPAR:Spikevax'

on pages 21 and 22, see Tables 9 and 10

Adverse Events in toddlers 24-36 months, and 37 months to less than 6 years, are listed in Table 9, which in summary we can see:

‘Grade 3 or above’ Adverse Events are defined:

‘Grade 3 = prevents daily activity; Grade 4 = emergency room visit or hospitalisation.’

In Infants/Toddlers aged 24-72 months, 204 Infants/Toddlers were either incapacitated from daily activity due to illness/injury or required an emergency room visit or hospitalisation.

Spikevax is therefore not Safe.

Moreover, after the second dose Infants 24-36 months suffered a Grade 3 or Grade 4 Adverse Event at a rate 5.33x greater than the placebo control group, based on the percentages.

After the second dose Toddlers 37-72 months suffered a Grade 3 or Grade 4 Adverse Event at a rate 3.12x greater than the placebo control group, based on the percentages.

Spikevax is therefore not Safe

Adverse Events in Babies 6 months to less than 24 months are listed in Table 10, which in summary we can see:

‘Grade 3 or above’ Adverse Events are defined:

‘Grade 3 = prevents daily activity; Grade 4 = emergency room visit or hospitalisation.’

Note - line 3 totals above are incorrect where they read: 11, 46, 12, 47.

These totals should read when all ‘Grade 3 or above’ below line 3 are counted:

Dose 1 Dose 2

Placebo: 12 (2.1) mRNA-1273: 50 (2.9) Placebo: 14 (2.7) mRNA-1273: 52 (3.3)

In Infants aged 6-24 months, 102 Infants were either incapacitated from daily activity due to illness/injury or required an emergency room visit or hospitalisation.

Spikevax is therefore not Safe.

Moreover, after the first dose Infants 6-24 months suffered a Grade 3 or Grade 4 Adverse Event at a rate 1.38x greater than the placebo control group, based on the percentages.

After the second dose Toddlers 37-72 months suffered a Grade 3 or Grade 4 Adverse Event at a rate 1.22x greater than the placebo control group, based on the percentages.

Spikevax is therefore not Safe

Moderna appears to be very selective with the data they offer to regulators

No matter how they try to present this 'safety' data, it is all bad for babies who never needed these drugs anyway, as the work of Professor John Ioannidis (et al) amply displays, where the IFR for babies/kids is in the order of 0.0003%

https://www.sciencedirect.com/science/article/pii/S001393512201982X

https://www.medrxiv.org/content/10.1101/2022.10.11.22280963v1?utm_source=substack&utm_medium=email

https://link.springer.com/article/10.1007/s10654-022-00853-w

all the best

Expand full comment